-
-
-
-
-
-
-
Liquidia (LQDA) and Pharmosa Biopharm Collaborate for Sustained-Release Inhaled Treprostinil Product in North America
-
-
-
-
-
-
-
Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million
-
-
-
-
-
-
-
Liquidia Reports Second Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Liquidia Technologies (LQDA) Announces $21.7 Million Private Placement of Common Stock
-
-
-
-
-
-
-
Liquidia Corporation Reports Full-Year 2020 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Liquidia Corporation Appoints Michael Kaseta Chief Financial Officer
-
-
-
-
-
-
-
Pre-Open Stock Movers 11/2: (DBVT) (EIGI) (CWH) Higher; (LQDA) (JNCE) (ON) Lower (more...)
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

